{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:36:21Z","timestamp":1759448181894,"version":"3.40.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10067-020-05543-0","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T11:02:58Z","timestamp":1610103778000},"page":"2829-2833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The U.S. Veterans Health Administration national giant cell arteritis (GCA) database cohort: incident ophthalmic complications in biopsy-negative GCA patients"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9562-2317","authenticated-orcid":false,"given":"Sarah H.","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9462-2078","authenticated-orcid":false,"given":"Meredith B.","family":"Morcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Scott","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0126-1275","authenticated-orcid":false,"given":"Bernard","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"issue":"2","key":"5543_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semarthrit.2017.04.001","volume":"47","author":"CS Crowson","year":"2017","unstructured":"Crowson CS, Matteson EL (2017) Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015. Semin Arthritis Rheum 47(2):253\u2013256","journal-title":"Semin Arthritis Rheum"},{"key":"5543_CR2","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","volume":"13","author":"C Dejaco","year":"2017","unstructured":"Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B (2017) Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nat Rev Rheum 13:578\u2013592","journal-title":"Nat Rev Rheum"},{"key":"5543_CR3","first-page":"300","volume":"47","author":"GM Bruce","year":"1949","unstructured":"Bruce GM (1949) Temporal arteritis as a cause of blindness; review of literature and report of a case. Trans Am Ophthalmol Soc 47:300\u2013316","journal-title":"Trans Am Ophthalmol Soc"},{"key":"5543_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/qjmed\/15.57.47","volume":"15","author":"WT Cooke","year":"1946","unstructured":"Cooke WT, Cloake PC (1946) Temporal arteritis: a generalized vascular disease. Q J Med 15:47\u201375","journal-title":"Q J Med"},{"key":"5543_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S0161-6420(93)31608-8","volume":"100","author":"PD Aiello","year":"1993","unstructured":"Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG (1993) Visual prognosis in giant cell arteritis. Ophthalmology 100:550\u2013555","journal-title":"Ophthalmology"},{"key":"5543_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","volume":"125","author":"SS Hayreh","year":"1998","unstructured":"Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125:509\u2013520","journal-title":"Am J Ophthalmol"},{"key":"5543_CR7","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","volume":"41","author":"MA Gonzalez-Gay","year":"1998","unstructured":"Gonzalez-Gay MA, Blanco R, Rodr\u00edguez-Valverde V, Mart\u00ednez-Taboada VM, Delgado-Rodriguez M, Figueroa M, Uriarte E (1998) Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 41:1497\u20131504","journal-title":"Arthritis Rheum"},{"key":"5543_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","volume":"79","author":"MA Gonzalez-Gay","year":"2000","unstructured":"Gonzalez-Gay MA, Garc\u00eda-Porr\u00faa C, Llorca J, Hajeer AH, Bra\u00f1as F, Dababneh A, Gonz\u00e1lez-Louzao C, Rodriguez-Gil E et al (2000) Visual manifestations of giant cell arteritis: trends and clinical spectrum in 161 patients. Medicine (Baltimore) 79:283\u2013292","journal-title":"Medicine (Baltimore)"},{"key":"5543_CR9","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1056\/NEJMra1413352","volume":"372","author":"V Biousse","year":"2015","unstructured":"Biousse V, Newman NJ (2015) Ischemic optic neuropathies. N Engl J Med 372:2428\u20132436","journal-title":"N Engl J Med"},{"issue":"8","key":"5543_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nrrheum.2017.98","volume":"13","author":"A Soriano","year":"2017","unstructured":"Soriano A, Muratore F, Pipitone N, Boiardi L, Cimino L, Salvarani C (2017) Visual loss and other cranial ischaemic complications in giant cell arteritis. Nat Rev Rheumatol 13(8):476\u2013484","journal-title":"Nat Rev Rheumatol"},{"issue":"22","key":"5543_CR11","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1001\/jama.2016.5444","volume":"315","author":"F Buttgereit","year":"2016","unstructured":"Buttgereit F, Dejaco C, Matteson EL, Dasgupta B (2016) Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA 315(22):2442\u20132458","journal-title":"JAMA"},{"issue":"2","key":"5543_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00296-018-4157-3","volume":"39","author":"G Keser","year":"2019","unstructured":"Keser G, Aksu K (2019) Diagnosis and differential diagnosis of large-vessel vasculitides. Rheumatol Int 39(2):169\u2013185","journal-title":"Rheumatol Int"},{"key":"5543_CR13","doi-asserted-by":"publisher","unstructured":"Chung SH, Morcos M, Ng B (2019) Determinants of positive temporal artery biopsies in the veterans\u2019 health administration national database cohort. Arthritis Care Res (Hoboken). https:\/\/doi.org\/10.1002\/acr.23897","DOI":"10.1002\/acr.23897"},{"key":"5543_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3899\/jrheum.140318","volume":"42","author":"E De Smit","year":"2015","unstructured":"De Smit E, Palmer A, Hewitt AW (2015) Projected worldwide disease burden from giant cell arteritis by 2050. J Rheumatol 42:119\u2013125","journal-title":"J Rheumatol"},{"key":"5543_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3899\/jrheum.140188","volume":"42","author":"AG Singh","year":"2015","unstructured":"Singh AG, Kermani TA, Crowson CS, Weyand CM, Matteson EL, Warrington KJ (2015) Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort. J Rheum 42:309\u2013315","journal-title":"J Rheum"},{"key":"5543_CR16","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","volume":"77","author":"C Dejaco","year":"2018","unstructured":"Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, Brouwer E et al (2018) EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 77:636\u2013643","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05543-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05543-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05543-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T16:08:17Z","timestamp":1623254897000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05543-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5543"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05543-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"3 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}